Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Since the advantage of adding chemotherapy to surgical resection of early-stage non-small-cell lung cancer was demonstrated a few years ago, the strategy has…
NEW YORK (Reuters Health) – Statins may be overused in patients without cardiovascular disease, according to a report in Archives of Internal Medicine. The researchers pooled data from…
NEW YORK (Reuters Health) – Two reports today in two separate journals — a meta-analysis and a large retrospective study — provide more evidence linking the thiazolidinedione rosiglitazone…
NEW YORK (Reuters Health) – Patients taking clopidogrel because of their high risk for cardiovascular events are more likely to have a major event if they carry the…
NEW YORK (Reuters Health) – Azithromycin is not only an effective treatment for bronchiolitis obliterans syndrome (BOS) that occurs in many lung transplant patients, it can also prevent…
NEW YORK (Reuters Health) – The notable accumulation of visceral fat that occurs in some patients with HIV who are on antiretroviral drugs can be reduced substantially by…
NEW YORK (Reuters Health) – While some patients with acute coronary syndrome (ACS) and elevate natriuretic peptide levels can benefit from treatment with various suppressors of the renin-angiotensin-aldosterone…
NEW YORK (Reuters Health) – The adverse effects of conventional amphotericin B for treating acute cryptococcal meningitis in AIDS patients can be reduced significantly by using the liposomal…
NEW YORK (Reuters Health) – Radiographic progression of rheumatoid arthritis is reduced to comparable degrees by DMARDs (disease modifying anti-rheumatic drugs), glucocorticoids, biologics and combination treatments, a Danish…
NEW YORK (Reuters Health) – Patients with non-small-cell lung cancer harboring susceptibility mutations in the epidermal growth factor receptor (EGFR) did better with gefitinib given as first-line therapy…
